The content on this site is intended for healthcare professionals only
Prof Richard Sullivan speaks to ecancer about the effect on cancer treatment in the age of COVID-19 and the current worldwide impact.
He explains that at the moment the data coming out is mostly epidemiological and that there just isn't enough data out there on cancer and COVID-19 patients to inform clinical judgements.
Prof Sullivan also discusses the effect of the spread of the virus in low-middle-income countries and believes that the low infection rates are down to the fact that these countries are unable to rigorously test their populations.
He also believes that the impact of the lockdowns on access to cancer treatments could be a major cause for concern.
Prof Sullivan asserts that any piece of information we have on the effect of COVID-19 on cancer patients is essential going forward.
The Vanessa Moss Prize: celebrating research into cancer health disparities
Gaza's cancer patients: Navigating the dual struggle of illness and war
Cancer in emergencies: What can we do better to protect the most vulnerable?
Introducing oncology to undergraduate medical and allied health sciences students
The Southeast Asian Breast Cancer Symposium; background, aims and successes
Decision making in paediatric oncology
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours
Advocacy that impacts patients outcomes in Africa - challenges and opportunities
African oncologists interaction with pharmaceutical industry
